 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 August 1994 | Volume 121 Issue 3 | Pages 196-197
*Deceased.
Author and Article Information
From the Naval Medical Center, Portsmouth, Virginia.
BRIEF COMMUNICATION
Glucocerebrosidase Treatment of Type I Gaucher Disease with Severe Pulmonary Involvement
Requests for Reprints: LCDR Kevin O'Neil, MC, Pulmonary Division, Ward 5A, Naval Medical Center, 620 John Paul Jones Circle, Portsmouth, VA 23708-5100.
Disclaimer: The opinions expressed are those of the authors and do not represent those of the Navy or the Department of Defense.
This article has been cited by other articles:
|
|
 |
|
  O. Goitein, D. Elstein, A. Abrahamov, I. Hadas-Halpern, E. Melzer, E. Kerem, and A. Zimran Lung involvement and enzyme replacement therapy in Gaucher's disease QJM, August 1, 2001; 94(8): 407 - 415. [Abstract] [Full Text] [PDF]
|
|
Article
